Archford Capital Strategies’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Archford Capital Strategies’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-680	Closed	–	–	573
2019 Q2	$0	Hold	680	–	–	﹤0.01%	584
2019 Q1	$0	Hold	680	–	–	﹤0.01%	558
2018 Q4	$0	Hold	680	–	–	﹤0.01%	560
2018 Q3	$0	Hold	680	–	–	﹤0.01%	726
2018 Q2	$0	Hold	680	–	–	﹤0.01%	777
2018 Q1	$1K	Buy	+680	New	+$274	﹤0.01%	649
2017 Q2	–	Sell	-680	Closed	–	–	753
2017 Q1	$0	Hold	680	–	–	﹤0.01%	793
2016 Q4	$0	Hold	680	–	–	﹤0.01%	812
2016 Q3	$0	Hold	680	–	–	﹤0.01%	777
2016 Q2	$0	Buy	+680	New	+$117	﹤0.01%	794
2016 Q1	–	Sell	-680	Closed	-$1K	–	774
2015 Q4	$1K	Hold	680	–	–	﹤0.01%	837
2015 Q3	$0	Hold	680	–	–	﹤0.01%	773
2015 Q2	$0	Hold	680	–	–	﹤0.01%	762
2015 Q1	$461	Hold	680	–	–	﹤0.01%	708
2014 Q4	$1K	Hold	680	–	–	﹤0.01%	695
2014 Q3	$0	Hold	680	–	–	﹤0.01%	909
2014 Q2	$340	Hold	680	–	–	﹤0.01%	891
2014 Q1	$211	Buy	+680	New	+$253	﹤0.01%	864

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Archford Capital Strategies's GCVRZ Position: Q3 2019 in Review

Archford Capital Strategies sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2019, closing a stake of 680 shares.

Archford Capital Strategies first reported a position in GCVRZ in Q1 2014 and held it in 18 quarters. The position peaked at $1K in Q1 2018. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2019.

Archford Capital Strategies reported no remaining Sanofi Contingent Value Rights position as of Q3 2019 after selling out during the quarter.
Archford Capital Strategies sold 680 Sanofi Contingent Value Rights shares in Q3 2019.
Archford Capital Strategies first reported a position in Sanofi Contingent Value Rights in Q1 2014 and held it in 18 quarters.
Archford Capital Strategies's Sanofi Contingent Value Rights position peaked at $1K in Q1 2018.
103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2019.

Based on Archford Capital Strategies's 13F filing for Q3 2019, filed 23 Oct 2019.